Ongoing trials are investigating the safety and efficacy of inhaled insulin in the treatment of diabetes. This new delivery system allows the insulin to be quickly absorbed into the blood stream and begin working immediately. Rapid absorption of the inhaled insulin is especially helpful around mealtime by improving glycemic control.

Sansum Diabetes Research Institute is the first research site to investigate a new intravascular fluorescent glucose sensor designed for use in intensive care units.  Preliminary studies indicating good accuracy are very promising.

Research related to diabetes prevention is part of a multicenter national study looking at genetic markers in family members of people with type 1 diabetes to see if they can predict which family members have a high risk of developing diabetes. All of the data is collected in a national database to be used in future diabetes prevention studies.

Sansum Diabetes Research Institute is conducting a number of studies in pregnant women with diabetes. Click here for information about ongoing studies related to diabetes and pregnancy.

Sansum Research always has new studies in development and needs volunteers to help with research. If you would like to be in the clinical trials database, please complete the enrollment form or if you have any questions, feel free to contact the clinical trials department at 805-682-7638. Staff members and their extensions are listed below.

Patty Schiffler, CCRC x229
Uzma Khan,  x203
Wendy Bevier, PhD x207
Howard Zisser, M.D. x255